See also this year's filing and all EDGAR filings for this company.
PDF Report 0001355250_2017_Innovation_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001355250, Innovation Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 6,608,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,311,000 |
| 2 | PropertyPlantAndEquipmentNet | 90,000 |
| 3 | remainder_Assets | 436,000 |
| 4 | LiabilitiesCurrent | 8,481,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,784,669 |
| 9 | ResearchAndDevelopmentExpense | 7,506,562 |
| 10 | remainder_Expenses | 1,703,381 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -197,017 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,445,000 |
| 1 | Liabilities | 8,481,000 |
| 2 | Expenses | 14,994,612 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 2,964,000 |
| 5 | NetIncome | -15,191,629 |
| 6 | ComprehensiveNetIncome | -15,191,629 |
| 7 | BaseVar | 17,558,814 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.876 |
| 9 | EconomicCapitalRatio | 1.33 |